Abstract:Ethnopharmacological relevance Zexieyin formula (ZXYF), a traditional Chinese herbal formula recorded in the Huangdi Neijing to have efficacy in relieving spleen dampness and heat accumulation syndrome, which is also the key pathogenesis of atherosclerosis (AS). The efficacy has demonstrated by our previous studies. However, the intrinsic mechanism of ZXYF for treating vascular inflammation and the effect of inflammatory response on plaque are not known. Currently, plaque stabilization is crucial for the prognosis of AS. Aim of the study Our study mainly focused on the therapeutic effects of ZXYF on high-fat diet (HFD)-induced vascular inflammation and vulnerable plaques (VP) in mice and explored its underlying mechanism. Methods and materials Male apolipoprotein E knockout (APOE−/−) mice were fed HFD for 8 weeks to establish a VP model. During this period, the mice were also administered ZXYF, while atorvastatin (ATO) was used as a positive control. Aortic plaque area and morphology were detected by oil red staining and HE staining. Aortic plaque collagen content was detected by Masson staining. M1/M2 type macrophages were detected using immunofluorescence (IF). The study analyzed the levels of inflammation-related cytokines (IL-1β, IL-10, IL-6), MAPK/NF-κB pathway proteins, and NLRP3 inflammasomes (NLRP3, Caspase-1) using Western blot. Additionally, the levels of matrix metalloproteinase (MMP)-2 and MMP-9 and α-smooth muscle actin (α-SMA) in the aorta were analyzed using immunohistochemistry (IHC). The plaque instability index was calculated for each group using the vulnerable plaque formula. Results In this study, APOE−/− mice were fed high-fat diet for 8 weeks. The results of oil-red and HE staining indicated a significant increase in the aortic plaque area of the mice, which exhibited a typical VP phenotype. ZXYF and ATO significantly improved AS plaques and prevented plaque rupture. HFD exacerbated vascular inflammation, stimulated macrophage conversion to M1-type through the MAPK/NF-κB signaling pathway, and released pro-inflammatory factors such as interleukin (IL)-1β, IL-1α, and IL-6. These factors activated NLRP3 inflammatory vesicles, leading to cellular death. However, ZXYF could reverse this trend and promote the conversion of macrophages to the anti-inflammatory M2 type. The anti-inflammatory effect of ATO was not significant. Moreover, HFD promoted the release of MMP-2 and MMP-9 from macrophages, which degraded plaque collagen, and induced a decrease in plaque SMC content, resulting in a thinning of the plaque fibrous cap. In contrast, ZXYF inhibited the decomposition of plaque collagen and increased the content of plaque smooth muscle cells (SMC) by reducing macrophage secretion of MMPs, thereby stabilizing plaques. Although ATO could reverse the decrease in plaque collagen and SMC content, its effect on MMPs was not significant. Finally, we calculated the vulnerability index to assess the overall risk of the plaque vulnerability phenotype. In line with these findings, ZXYF and ATO were able to effectively reverse the increase in the vulnerability index caused by HFD and lower the risk of adverse cardiovascular events. Conclusion Our results suggested that ZXYF could reduce inflammation and increase plaque stability by inhibiting the MAPK/NF-κB signaling pathway, which provided a theoretical basis for clinical application and subsequent research.

Tongxinluo May Alleviate Inflammation and Improve the Stability of Atherosclerotic Plaques by Changing the Intestinal Flora

Tongxinluo May Stabilize Atherosclerotic Plaque Via Multiple Mechanisms Scanning by Genechip.

Traditional Chinese Medication Tongxinluo Dose-Dependently Enhances Stability of Vulnerable Plaques: A Comparison with A High-Dose Simvastatin Therapy

Tongxinluo Inhibits Formation of Vascular Adventitia Damage-Induced Atherosclerotic Plaques and CD40 Expression in Rabbits

Chinese medicine tongxinluo significantly lowers serum lipid levels and stabilizes vulnerable plaques in a rabbit model

Tongxinluo Mitigates Atherogenesis by Regulating Angiogenic Factors and Inhibiting Vasa Vasorum Neovascularization in Apolipoprotein E-deficient Mice.

Xiaoyaosan Prevents Atherosclerotic Vulnerable Plaque Formation Through Heat Shock Protein/glucocorticoid Receptor Axis-Mediated Mechanism.

Expression of Inflammatory Factors of Atherosclerosis Plaque and Intervening Effects of "Tongxinluo Capsule"

Traditional Chinese Medication Tongxinluo Attenuates Lipidosis in Ox-LDL-Stimulated Macrophages by Enhancing Beclin-1-Induced Autophagy

Krill Oil Combined with Bifidobacterium Animalis Subsp. Lactis F1-7 Alleviates the Atherosclerosis of ApoE−/− Mice

Yang-Xin-Shu-Mai granule alleviates atherosclerosis by regulating macrophage polarization via the TLR9/MyD88/NF-κB signaling pathway

GW24-e1007 Recipe of Removing Both Phlegm and Blood Stasis Inhibits Atherosclerosis Progression and Promotes Plaque Stability in a Rabbit Mode

Effects of Herbs with the Effect of Activating Blood Circulation or Nourishing Qi or Elimating Phlegm on Inflammatory Reaction in Atherosclerotic Plaque in Aorta of ApoE-gene Knockout Mice

Aqueous Extract of Rhubarb Stabilizes Vulnerable Atherosclerotic Plaques Due to Depression of Inflammation and Lipid Accumulation.

Transcriptomic analysis reveals the critical role of Chemokine signaling in the anti-atherosclerosis effect of Xuefu Zhuyu Decoction

Shenlian extract improves atherosclerosis by relieving adventitial inflammation

ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE−/− mice to attenuate vascular inflammation and increase plaque stability

Suxiaojiuxin Pill Enhances Atherosclerotic Plaque Stability by Modulating the MMPs/TIMPs Balance in ApoE-deficient Mice.

ShenLian Extract Enhances TGF-β Functions in the Macrophage-SMC Unit and Stabilizes Atherosclerotic Plaques

The effect and mechanism of inulin on atherosclerosis is mediated by the characteristic intestinal flora and metabolites

Metabolite Acetyl-L-carnitine Participates in Bifidobacterium Animalis F1-7 to Ameliorate Atherosclerotic Inflammation by Downregulating Thetlr4/nf-Κb Pathway